Neuromyelitis optica (NMOSD): open trials in Germany

• NCT05966467

  Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies

  Research · Alexion Pharmaceuticals, Inc.

  Dresden · Essen · München

  Registry updated 2026-10-13

• NCT07010302

  Rituximab Versus Ravulizumab, Inebilizumab, Satralizumab, and Eculizumab in NMOSD

  Trial Treatment · Phase 4 · Massachusetts General Hospital

  Charité Universitätsmedizin Berlin, Berlin

  Registry updated 2026-09-24

• NCT05566769

  Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD

  Trial Treatment · Ad scientiam

  Universitätsklinikum Carl Gustav Carus, Dresden · Universitätsklinik Essen, Essen · University Munich, Munich · Hopital Rechts der Isar der Technischen Universitat Munchen, Munich

  Registry updated 2025-04-10

All Neuromyelitis optica (NMOSD) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error